breast cancer biomarker discovery: proteomics and genomics approaches
نویسندگان
چکیده
abstract breast cancer is one of the major health problems of the eastern world. regardless of the survival rate improvement with progression in screening and adjuvant systemic therapies, still one – third of the patients with primary breast cancer have recurrence of micro metastasis after 10 years. it is important to discover a reliable biomarker for detection of breast cancer. the underlying molecular mechanism of the disease needs to be better understood. allied to genomics, proteomics technologies promise to be valuable for identifying new markers that improve screening, early diagnosis, prognosis and prediction of therapeutic response or toxicity, as well as the identification of new therapeutic targets. in this review, we present proteomic and genomic sciences have been used for differential analysis of breast cancer to find molecular changes of cancer for detection candidate biomarkers.
منابع مشابه
Proteomics for Cancer Biomarker Discovery
Background: If we are to successfully treat cancer, we must understand the biologic underpinnings in conjunction with early diagnosis. Genome-wide expression studies have advanced the research of many cancers. Nevertheless, understanding which genes are expressed in a tumor is not equivalent to knowing which proteins are being produced. Proteomics hold great promise for careful examination of t...
متن کاملProteomics for cancer biomarker discovery.
The emergence of novel technologies allows researchers to facilitate the comprehensive analyses of genomes, transcriptomes, and proteomes in health and disease. The information that is expected from such technologies may soon exert a dramatic change in the pace of cancer research and impact dramatically on the care of cancer patients. These approaches have already demonstrated the power of mole...
متن کاملAn Integrative Genomics Approach to Biomarker Discovery in Breast Cancer
Genome-wide association studies (GWAS) have successfully identified genetic variants associated with risk for breast cancer. However, the molecular mechanisms through which the identified variants confer risk or influence phenotypic expression remains poorly understood. Here, we present a novel integrative genomics approach that combines GWAS information with gene expression data to assess the ...
متن کاملProteomics in Biomarker Discovery for Prostate Cancer
The use of prostate specific antigen (PSA)-based screening of prostate cancer (PCa) results with overdiagnosis of the disease, unnecessary biopsies and high medical cost treatments. The discovery of new biomarkers in blood, urine or tissue that will permit early detection and treatment of patients with aggressive disease and, concomitantly, avoid overtreatment for low risk cases are urgently ne...
متن کاملSalivary proteomics for oral cancer biomarker discovery.
PURPOSE This study aims to explore the presence of informative protein biomarkers in the human saliva proteome and to evaluate their potential for detection of oral squamous cell carcinoma (OSCC). EXPERIMENTAL DESIGN Whole saliva samples were collected from patients (n = 64) with OSCC and matched healthy subjects (n = 64). The proteins in pooled whole saliva samples of patients with OSCC (n =...
متن کاملThe network biomarker discovery in prostate cancer from both genomics and proteomics levels
Both mass spectrometry (MS) and microarray technologies are very promising for discovery of new biomarkers for clinical diagnosis. In order to identify the high-confidence biomarkers from expression datasets, we proposed a new pipeline for biomarker discovery, in which the disease information of proteins/genes, different levels of expression profiles (microarray datasets and proteomics datasets...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of cancer preventionجلد ۶، شماره ۰۳، صفحات ۴۵-۵۳
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023